Showing results (1-10 of 1,224) with videos related to
Sort By:
Pageof 123
Journal of Diabetes and Metabolic Disorders|May 17, 2021
Ramadan fasting and diabetes, latest evidence and technological advancements: 2021 updateAli Tootee, Bagher LarijaniDaru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|June 27, 2020
Diabetes management during Ramadan amid Covid-19 pandemicAli Tootee, Ensieh Nasli Esfahani, Bagher LarijaniJournal of Diabetes and Metabolic Disorders|November 20, 2014
Comparability of hemoglobin A1c level measured in capillary versus venous blood sample applying two point-of-care instrumentsTahereh Keramati, Farideh Razi, Ali Tootee, et al.Systematic Reviews|January 28, 2018
Safety and efficacy of hematopoietic and mesanchymal stem cell therapy for treatment of T1DM: a systematic review and meta-analysis protocolSedigheh Madani, Bagher Larijani, Abbas Ali Keshtkar, et al.BMJ Open|March 13, 2023
Ramadan fasting and type 1 diabetes: a scoping review protocolAli Tootee, Fatemeh Bandarian, Nazli Namazi, et al.Journal of Diabetes and Metabolic Disorders|November 21, 2022
Epidemiology of diabetes in Iran: A scoping review of studies published during 2015-2019Fatemeh Gharishvandi, Hamed Moheimani, Shahnaz Esmaeili, et al.Primary Care Diabetes|December 15, 2015
Effectiveness of short message service-based intervention (SMS) on self-care in type 2 diabetes: A feasibility studyMaryam Peimani, Camelia Rambod, Maryam Omidvar, et al.Medical Journal of the Islamic Republic of Iran|September 21, 2022
Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte PopulationsAli Tootee, Behrouz Nikbin, Ensieh Nasli Esfahani, et al.Journal of Diabetes and Metabolic Disorders|July 5, 2021
Assessment of immune-alternations and their correlations with therapeutic outcomes of transplantation of autologous Mesenchymal and Allogenic fetal stem cells in patients with type 1 diabetes: a study protocolAli Tootee, Behrouz Nikbin, Aziz Ghahary, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|February 4, 2021
Immunopathology of Type 1 Diabetes and Immunomodulatory Effects of Stem Cells: A Narrative Review of the LiteratureAli Tootee, Behrouz Nikbin, Aziz Ghahary, et al.Pageof 123